Inhalation Sciences Investor Relations Material
Latest events
Study Result
Inhalation Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Inhalation Sciences
Access all reports
Inhalation Sciences Sweden AB (ISAB) develops and markets laboratory equipment designed for inhalation research. The company’s primary offerings include systems such as PreciseInhale, which allows scientists to measure how inhaled particles behave in the lungs, and DissolvIt, a tool for in vitro simulation of particle dissolution and absorption in the lung epithelium. Their portfolio also includes specialized modules like XposeALI, for 3D cell exposure, and other equipment used in preclinical testing of inhalation drugs and toxicity studies. Inhalation Sciences serves industries involved in respiratory medicine, toxicology, and aerosol science. The company is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ISAB
Country
🇸🇪 Sweden